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1. Introduction 
Basic textbooks of pharmacology warn against 
simultaneous alcohol consumption during the treat- 
ment of patients by modern psychopharmaca nd 
declare acute alcohol intoxication a strict contra- 
indication for the administration of most of these 
drugs. Liver injuries are reported to occur sometimes 
as a side effect in the treated patients. For the thia- 
xanthene derivative Chloroprothixene, it has been 
experimentally established that it significantly 
prolongs the ethanol anesthesia [l] . 
Strong inhibitory activity of Chloroprothixene 
and Chloropromazine on horse liver alcohol 
dehydrogenase (EC. 1.1.1.1.) (LADH) reported in this 
paper, might be related to the pharmacologically 
undesirable effects since, in preliminary experiments, 
the human enzyme was also strongly inhibited by the 
tested drugs. 
2. Materials and methods 
Horse LADH was isolated according to the method 
of Theorell et al. [2]. Enzyme concentration was 
determined spectroscopically [3] and its purity on 
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Fig.1. Absorption spectra of free Chloroprothixene (so-o-) 
and of the drug bound to horse LADH (-a). 
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the basis of eZsO = 0.455 mg-’ cm* [4] was 80-90%. 
Human LADH preparations were roughly purified by 
fractionation of the crude homogenate by ammonium 
sulphate according to [ 5 ] . The human enzyme was 
found to be of the ‘normal’ type in terms of von 
Wartburg’s [6] classification. 
NAD was Boehringer’s product (grade II). 
Chloroprothixene, Chloropromazine and Prothiadene 
were hydrochlorides of the purity required for the 
manufacture of commercial remedies. The content of 
the pharmacologically inactive cis forms of Prothia- 
dene and Chloroprothixene was less than 3%. Other 
common compounds were of A.R. grade. 
For kinetic measurements a Beckman Model DU 
Spectrophotometer was used either with the standard 
equipment (spectrophotometry) or with its commer- 
cial fluorometric attachement. Absorbance or fluor- 
escence intensity increase in time were scanned by 
means of the Energy Recording Attachement ERA of 
Beckman and the Honeywell recording millivoltmeter. 
All optical measurements were carried out at 23S”C. 
Difference spectrum of the bound and free Chloro- 
prothixene was measured on a Cary 118 spectrophoto- 
meter in a mixture of 51 PN horse LADH and 10 I.IM 
Chloroprothixene which ensures at least 96% inhibitor 
in the bound form. (Reference beam passed through 
two cuvettes with the same compounds separated.) 
Spectrum of the bound drug shown in fig. 1 represents 
the superposition of the difference spectrum of the 
free drug. 
3. Results and discussion 
The inhibitor concentrations I,, which cause a 50% 
inhibition of ethanol oxidation by the enzyme are 
shown in table 1. I,, strictly equals to the inhibition 
Table 1 
Compound Structurea TO.5 at PH 7 
(/JM)~ 
IO.5 at pH 10 
(rMYc 
Chloroprothixene 1.3 3.5 
CH-R 
Chloropromazine 17.5 25.0 
CH,-R 
Prothiadene 190 > 300 
033 
CH-R 
c 
298 
R: -(CH,), NW&), 
4.0 ml of 7 mM ethanol and 0.35 mM NAD in a 0.1 @ Na-phosphate buffer pH 7 (measured fluoro- 
metrically) 
3.0 ml of 11 mM ethanol and 0.5 mM NAD in a 0.67 M NaOH-glycine buffer pH 10 (measured spectro- 
photometrically). 
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constant q only under specific prerequisits in case of 
a noncompetitive behaviour of the inhibitor. Never- 
theless it can serve for a comparison of the inhibitory 
power of related compounds. 
The strongest inhibitor among the tranquilisers 
tested up to now is the Chloroprothixene. Though 
it is not possible to set up structural requirements for 
the inhibition from this small series it seems clear 
that even a minor change of the heteroaromatic system 
brings about great change in the inhibition power. 
(Low affinity of the dibenzothiepine thymoleptic 
drug Prothiadene to the enzyme might also depend on 
the absence of the chlorine atom.) The dependence 
of the inhibition intensity on pH suggests the possi- 
bility that the side chain nitrogen atom with its 
positive charge may also be involved. 
Kinetic behaviour of the Chloroprothixene shown 
in table 2 indicates that the ‘tranquilizer binding site’ 
of horse LADH is different from the coenzyme 
binding site. Possible overlapping of it with the 
substrate binding site remains to be examined. (It is not 
proven by the found mixed-competitive pattern vs. 
ethanol due to the validity of the Theorell-Change 
mechanism and due to the experimental conditions 
used; cf. J. Kovti, in preparation.) 
The non-competitiveness of Chloroprothixene vs. 
NAD also excludes the possibility to explain the 
inhibition being caused by direct binding of the drug 
with the free coenzyme. 
Existence of a binary enzyme-Chloroprothixene 
complex supported by kinetic pattern has been proven 
by the W absorption spectra (fig. 1). Both absorption 
maxima of Chloroprothixene at 269 and 325 nm get 
Table 2 
Kinetic parameters of the inhibition of horse LADH by 
Chloroprothixene 
Substrate Pattern (Ki) slope (Ki) intercept 
(PM) (rM) 
NAD 
Ethanol 
Noncompetitive 1.4 1.4 
Mixed-competitive 0.8 1.6 
Measured fluorometrically on 0.1 w Na-phosphate buffer pH 
7.0 with the final enzyme concentration of 0.1 PN. Variable 
ethanol, NAD and inhibitor concentrations varied between 
200-5000 PM, 34-340 PM and O-5 MM respectively. Con- 
centrations of saturating components were 5800 MM and 680 
PM for ethanol and NAD respectively. 
red-shifted upon binding and the shoulder at 290 nm 
becomes more pronounced. 
In order to find out whether the observed 
tranquilizer-enzyme interaction could be of any 
importance in man the influence of Chloro- 
prothixene on a crude LADH preparation from human 
liver has been tested. The activity of this impure 
enzyme dropped under 70% in the presence of 10 PM 
Chloroprothixene. This favours the possibility of a 
direct influence of tranquilizers on alcohol metabolism 
in man via their binding with the LADH. 
Recently a very strong bond between the rat LADH 
and the carcinogenic aminoaz dye, the 3’-methyl-4- 
dimethylaminoazobenzene has been reported [7]. 
In the cited case the enzyme seems to serve as some 
sort of target (or storage) protein for the noxious 
drug (although this one does not inhibit the enzymic 
activity). 
The speculative hypothesis on liver alcohol dehy- 
drogenase as a possible target protein for certain 
tranquilizers seems to deserve further attention. 
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